Differential Transformation of Ginsenosides from Panax ginseng by Lactic Acid Bacteria |
Chi, Hyun
(Department of Food and Nutrition, Seoul National University)
Lee, Bo-Hyun (Department of Food and Nutrition, Seoul National University) You, Hyun-Ju (Department of Food and Nutrition, Seoul National University) Park, Myung-Soo (Department of Hotel Culinary Art, Anyang Technical College) Ji, Geun-Eog (Department of Food and Nutrition, Seoul National University) |
1 | Akao, T., M. Kanaoka, and K. Kobashi. 1998. Appearance of compound K, a major metabolite of ginsenoside Rb1 by intestinal bacteria, in rat plasma after oral administration---Measurement of compound K by enzyme immunoassay. Biol. Pharm. Bull. 21: 245-249 DOI |
2 | Bae, E. A., M. J. Han, M. K. Choo, S. Y. Park, and D. H. Kim. 2002. Metabolism of 20(S)- and 20(R)-ginsenoside Rg3 by human intestinal bacteria and its relation to in vitro biological activities. Biol. Pharm. Bull. 25: 58-63 DOI ScienceOn |
3 | Choi, E. K. and G. E. Ji. 2005. Food microorganisms that effectively hydrolyze O-glycoside but not C-glycoside isoflavones in Puerariae radix. J. Food Sci. 70: C25-C28 DOI ScienceOn |
4 | Kim, H. Y., J. H. Yang, and G. E. Ji. 2005. Effect of bifidobacteria on production of allergy-related cytokines from mouse spleen cells. J. Microbiol. Biotechnol. 15: 265-268 과학기술학회마을 DOI ScienceOn |
5 | Lee, D. S., Y. S. Kim, C. N. Ko, K. H. Cho, H. S. Bae, K. S. Lee, J. J. Kim, E. K. Park, and D. H. Kim. 2002. Fecal metabolic activities of herbal components to bioactive compounds. Arch. Pharm. Res. 25: 165-169 DOI ScienceOn |
6 | Han, B. H., M. H. Park, Y. N. Han, L. K. Woo, U. Sankawa, S. Yahara, and O. Tanaka. 1982. Degradation of ginseng saponins under mild acidic conditions. Planta Med. 44: 146-149 DOI ScienceOn |
7 | Karikura, M., T. Miyase, H. Tanizawa, T. Taniyama, and Y. Takino. 1991. Studies on absorption, distribution, excretion and metabolism of ginseng saponins. VII. Comparison of the decomposition modes of ginsenoside-Rb1 and -Rb2 in the digestive tract of rats. Chem. Pharm. Bull. 39: 2357-2361 DOI ScienceOn |
8 | Wu, J. Y., B. H. Gardner, C. I. Murphy, J. R. Seals, C. R. Kensil, J. Recchia, G. A. Beltz, G. W. Newman, and M. J. Newman. 1992. Saponin adjuvant enhancement of antigen-specific immune responses to an experimental HIV-1 vaccine. J. Immunol. 148: 1519-1525 |
9 | Huang, K. C. 1999. The Pharmacology of Chinese Herbs. CRC Press, Florida |
10 | Mochizuki, M., C. Y. Yoo, K. Matsuzawa, K. Sato, I. Saiki, S. Tono-oda, K. Samukiwa, and I. Azuma. 1995. Inhibitory effect of tumor metastasis in mice by saponins, ginsenoside Rb2, 20(R)- and 20(S)-ginsenoside Rg3, of Red ginseng. Biol. Pharm. Bull. 18: 1197-1202 DOI |
11 | Karikura, M., H. Kato, F. Shimada, and S. Yano. 1992. Studies on the enzyme immunoassay of bioactive constituents contained in oriental medicinal drugs. VI. Enzyme immunoassay of ginsenoside Rb1 from Panax ginseng. Chem. Pharm. Bull. 40: 314-317 DOI ScienceOn |
12 | Lee, F. C. 1992. Facts About Ginseng, the Elixir of Life. Hollyn International, New Jersey |
13 | Akao, T., H. Kida, M. Kanaoka, M. Hattori, and K. Kobashi. 1998. Intestinal bacterial hydrolysis is required for the appearance of compound K in rat plasma after oral administration of ginsenoside Rb1 from Panax ginseng. J. Pharm. Pharmacol. 50: 1155-1160 DOI ScienceOn |
14 | Tawab, M. A., U. Bahr, M. Karas, M. Wurglics, and M. Schubert-Zsilavecz. 2003. Degradation of ginsenosides in humans after oral administration. Drug Metab. Dispos. 31: 1065-1071 DOI ScienceOn |
15 | Sato, K., M. Mochizuki, I. Saiki, Y. C. Yoo, K. Samukawa, and I. Azuma. 1994. Inhibition of tumor angiogenesis and metastasis by a saponin of Panax ginseng-ginsenoside Rb2. metastasis by a saponin of Panax ginseng-ginsenoside Rb2. Biol. Pharm. Bull. 17:635-639 DOI ScienceOn |
16 | Hasegawa, H., J. W. Sung, and Y. Benno. 1997. Role of human intestinal Prevotela oris in hydrolyzing ginseng saponins. Planta Med. 63: 436-440 DOI ScienceOn |
17 | Park, S. Y., G. E. Ji, Y. T. Ko, H. K. Jung, Z. Ustunol, and J. J. Pestka. 1999. Potentiation of hydrogen peroxide, nitric oxide, and cytokine production in RAW 264.7 macrophage cells exposed to human and commercial isolates of Bifidobacterium. Int. J. Food Microbiol. 46: 231-241 DOI ScienceOn |
18 | Chang, H. M. 1986. Pharmacology and Application of Chinese Material Medica. Vol 1. World Scientific, Singapore |
19 | Bae, E. A., S. Y. Park, and D. H. Kim. 2000. Constitutive beta-glucosidases hydrolyzing ginsenoside Rb1 and Rb2 from human intestinal bacteria. Biol. Pharm. Bull. 23: 1481-1485 DOI ScienceOn |
20 | Kanaoda, M., T. Akao, and K. Kobashi. 1994. Metabolism of ginseng saponins, ginsenosides, by human intestinal bacteria. J. Trad. Med. 11: 241-245 |
21 | Hasegawa, H., J. H. Sung, S. Matsumiya, and M. Uchiyama. 1996. Main ginseng saponin metabolites formed by intestinal bacteria. Planta Med. 62: 453-457 DOI ScienceOn |
22 | Lee, B. H. and G. E. Ji. 2005. Effect of Bifidobacterium cell fractions on IL-6 production in RAW 264.7 macrophage cells. J. Microbiol. Biotechnol. 15: 740-744 과학기술학회마을 |
23 | Ko, S. R., K. J. Choi, K. Uchida, and Y. Suzuki. 2003. Enzymatic preparation of ginsenosides Rg2, Rh1, and F1 from protopanaxatriol-type ginseng saponin mixture. Planta Med. 69: 285-286 DOI ScienceOn |
24 | Lee, B. H., H. J. You, M. S. Park, B. Kwon, and G. E. Ji. 2006. Transformation of the glycosides from food materials by probiotics and food microorganisms. J. Microbiol. Biotechnol. 16: 497-504 과학기술학회마을 |